An observational study in Breast Cancer, sponsored by NHS Tayside. Completed at 1 site in United Kingdom. Open to female participants aged Up to 59 Years. Per ClinicalTrials.gov, last updated 2018-05-08.
Sponsored by NHS Tayside · Observational
This study will examine a new imaging technique called digital breast tomosynthesis (DBT) compared to standard mammography in women under 60 presenting with signs of breast cancer. The reason that we need to do this study is that standard mammography fails to detect the cancer in approximately 20% of these women because younger women have denser breast tissue. We hope that DBT will be more sensitive in detecting breast cancer than standard mammography.
NHS Tayside is the lead sponsor of 28 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women under 60 years of age with clinical or ultrasound suspicion of breast cancer
Exclusion Criteria:
Digital Breast Tomosynthesis
Sensitivity of DBT for breast cancer, compared with FFDM
Time frame: Two years
Accuracy of DBT compared with FFDM in assessment of tumour extent
Time frame: Two years
Relative accuracy of DBT and FFDM by breast density
Time frame: Two years
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NHS Tayside